Order Article Reprints

Di Cosimo S, Appierto V, Pizzamiglio S, Silvestri M, Baselga J, Piccart M, Huober J, Izquierdo M, de la Pena L, Hilbers FS, et al. Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy. International Journal of Molecular Sciences. 2020; 21(4):1386. https://doi.org/10.3390/ijms21041386

Di Cosimo, Serena, Valentina Appierto, Sara Pizzamiglio, Marco Silvestri, José Baselga, Martine Piccart, Jens Huober, Miguel Izquierdo, Lorena de la Pena, Florentine S. Hilbers, and et al. 2020. "Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy" International Journal of Molecular Sciences 21, no. 4: 1386. https://doi.org/10.3390/ijms21041386

Di Cosimo, S., Appierto, V., Pizzamiglio, S., Silvestri, M., Baselga, J., Piccart, M., Huober, J., Izquierdo, M., de la Pena, L., Hilbers, F. S., de Azambuja, E., Untch, M., Pusztai, L., Pritchard, K., Nuciforo, P., Vincent-Salomon, A., Symmans, F., Apolone, G., de Braud, F. G., ... Daidone, M. G. (2020). Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy. International Journal of Molecular Sciences, 21(4), 1386. https://doi.org/10.3390/ijms21041386